close
Advertisement
Can't connect right now! retry

add The News to homescreen

tap to bring up your browser menu and select 'Add to homescreen' to pin the The News web app

Got it!

add The News to homescreen

tap to bring up your browser menu and select 'Add to homescreen' to pin the The News web app

Got it!
September 17, 2020

SKMT diagnostic services

Lahore

September 17, 2020

LAHORE:Wyeth Pakistan Limited, an affiliate of Pfizer Pakistan Limited, and Shaukat Khanum Memorial Trust (SKMT) have entered into a partnership to enhance access of deserving patients to quality diagnostic services.

According to a press release issued here on Wednesday, this initiative is part of Wyeth and Pfizer’s programme “MASEEHA” and is in line with SKMT’s commitment to provide the highest quality laboratory diagnostic services to the people of Pakistan. The programme entails providing free-of-cost diagnostic services to a select group of patients including those suffering from Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA), Plaque Psoriasis (PsO), Juvenile Idiopathic Arthritis (JIA) and other inflammatory diseases, to start with.

Speaking at the signing ceremony of the contract, Dr. Asif Loya, Medical Director of SKMCH&RC, said, “We are pleased to join in this campaign to extend the reach of our quality diagnostic services to deserving patients. For more than a quarter of a century, Shaukat Khanum has been at the forefront of providing world-class cancer care to people all across Pakistan.” Syed Wajeeh, Country Manager of Wyeth Pakistan and Pfizer Pakistan, in his message said “We are committed to extending innovative solutions to patients who can benefit the most from them.” ***